Use of rituximab in focal glomerulosclerosis relapses after renal transplantation

Transplantation

Volumn 88, Issue 3, 2009, Pages 417-420

  Strologo, Luca Dello ^a   Guzzo, Isabella ^a   Laurenzi, Chiara ^a   Vivarelli, Marina ^a   Parodi, Angelica ^b   Barbano, Giancarlo ^b   Camilla, Roberta ^c   Scozzola, Floriana ^d   Amore, Alessandro ^c   Ginevri, Fabrizio ^b   Murer, Luisa ^d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Focal glomerulosclerosis; Posttransplant relapse; Rituximab

Indexed keywords

RITUXIMAB;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DYSPNEA; FOCAL GLOMERULOSCLEROSIS; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PALATE ITCH; PLASMAPHERESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PRURITUS; RELAPSE; SCHOOL CHILD; TONGUE ITCH; UNSPECIFIED SIDE EFFECT; WHEEZING;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD19; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PLASMAPHERESIS; PROTEINURIA; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 69449108619     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181aed9d7     Document Type: Article

References (27)

1. Weber S, Tonshoff B. Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: Clinical and genetic aspects. Transplantation 2005; 80(1 suppl): S128. (Pubitemid 41552923)
2. Ivanyi B. A primer on recurrent and de novo glomerulonephritis in renal allografts. Nat Clin Pract Nephrol 2008; 4: 446.
3. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006; 6: 2535.
4. Nozu K, Iijima K, Fujisawa M, et al. Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 2005; 20: 1660. (Pubitemid 41554486)
5. Pescovitz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006; 354: 1961.
6. Friedberg JW. Treatment of follicular non-Hodgkin's lymphoma: The old and the new. Semin Hematol 2008; 45(3 suppl 2): S2.
7. Zecca M, Nobili B, Ramenghi U, et al. Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. Blood 2003; 101: 3857. (Pubitemid 36857857)
8. Blaes AH, Peterson BA, Bartlett N, et al. Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: Results of a phase II trial. Cancer 2005; 104: 1661. (Pubitemid 41437429)
9. Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy: Report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol 2008; 87: 405.
10. Kamar N, Mengelle C, Rostaing L. Incidence of JC-virus replication after rituximab therapy in solid-organ transplant patients. Am J Transplant 2009; 9: 244.
11. Anolik JH, Campbell D, Felgar RE, et al. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 2003; 48: 455. (Pubitemid 36278014)
12. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 2.5. Chronic graft dysfunction. Late recurrence of primary glomerulonephritides. Nephrol Dial Transplant 2002; 17(suppl 4): 16.
13. Schachter AD, Harmon WE. Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 2001; 5: 406.
14. Srivastava RN, Kalia A, Travis LB, et al. Prompt remission of post-renal transplant nephrotic syndrome with high-dose cyclosporine. Pediatr Nephrol 1994; 8: 94. (Pubitemid 24042379)
15. Cochat P, Kassir A, Colon S, et al. Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 1993; 7: 50. (Pubitemid 23045337)
16. Ohta T, Kawaguchi H, Hattori M, et al. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001; 71: 628. (Pubitemid 32268063)
17. Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005; 5: 2907.
18. Nakayama M, Kamei K, Nozu K, et al. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 2008; 23: 481.
19. El Firjani A, Hoar S, Karpinski J, et al. Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant 2008; 23: 425. (Pubitemid 351767399)
20. Yabu JM, Ho B, Scandling JD, et al. Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 2008; 8: 222.
21. Kamar N, Faguer S, Esposito L, et al. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 2007; 67: 250. (Pubitemid 46605375)
22. Gossmann J, Scheuermann EH, Porubsky S, et al. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 2007; 20: 558. (Pubitemid 46701081)
23. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 2007; 20: 1066. (Pubitemid 350043850)
24. Marks SD, McGraw M. Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 2007; 22: 158. (Pubitemid 46138381)
25. Hristea D, Hadaya K, Marangon N, et al. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 2007; 20: 102.
26. Bayrakci US, Baskin E, Sakalli H, et al. Rituximab for post-transplant recurrences of FSGS. Pediatr Transplant 2009; 13: 240.
27. Plosker GL, Figgitt DP. Rituximab: A review of its use in non- Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003; 63: 803.